FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

36772011000001105: K-Cap 1mg capsules (Transdermal Ltd) 30 capsule 2 x 15 capsules (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Mar 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
112651401000001110 K-Cap 1mg capsules (Transdermal Ltd) 30 capsule 2 x 15 capsules (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
112651501000001114 K-Cap 1mg capsules (Transdermal Ltd) 30 capsule 2 x 15 capsules en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
K-Cap 1mg capsules (Transdermal Ltd) 30 capsule 2 x 15 capsules Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
K-Cap 1mg capsules (Transdermal Ltd) 30 capsule 2 x 15 capsules Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
K-Cap 1mg capsules (Transdermal Ltd) 30 capsule 2 x 15 capsules Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
K-Cap 1mg capsules (Transdermal Ltd) 30 capsule 2 x 15 capsules Is a Phytomenadione 1mg capsules 30 capsule true Inferred relationship Existential restriction modifier
K-Cap 1mg capsules (Transdermal Ltd) 30 capsule 2 x 15 capsules Has AMP K-Cap 1mg capsules (Transdermal Ltd) true Inferred relationship Existential restriction modifier
K-Cap 1mg capsules (Transdermal Ltd) 30 capsule 2 x 15 capsules Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
K-Cap 1mg capsules (Transdermal Ltd) 30 capsule 2 x 15 capsules VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
K-Cap 1mg capsules (Transdermal Ltd) 30 capsule 2 x 15 capsules VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
K-Cap 1mg capsules (Transdermal Ltd) 30 capsule 2 x 15 capsules Has specific active ingredient Phytomenadione true Inferred relationship Existential restriction modifier
K-Cap 1mg capsules (Transdermal Ltd) 30 capsule 2 x 15 capsules Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
K-Cap 1mg capsules (Transdermal Ltd) 30 capsule 2 x 15 capsules Legal category Legal category not applicable true Inferred relationship Existential restriction modifier
K-Cap 1mg capsules (Transdermal Ltd) 30 capsule 2 x 15 capsules Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
K-Cap 1mg capsules (Transdermal Ltd) 30 capsule 2 x 15 capsules Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start